New Workshop planned on risk assessment of endocrine disrupting chemicals – case studies

In their September meeting, the ECETOC Scientific Committee approved a Workshop to further develop the guidance to risk assess endocrine disrupting chemicals, the potency concept, specificity and human relevence. The scheme developed by the Task Force in identifying endocrine disrupting effects has been well accepted and the German Federal Institute for Risk Assessment (BfR) has also developed a similar scheme. Dr. van Ravenzwaay, Dr. Bars and Dr. Galay-Burgos will organise a smaller group within the same Task Force (tox and ecetox) to develop the criteria further and then share/test it with attendees of the related previous Workshop for discussion.